Clinical Trials Directory

Trials / Completed

CompletedNCT04490785

Mri characterIzation of Troponin Elevation After Cardiac Surgery

Characterization of Postoperative Myocardial Lesions by Cardiac MRI and Anatomo-biological Correlations With Serum Troponin in Cardiac Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiac surgery under cardiopulmonary bypass (CPB) induces myocardial ischemia-reperfusion injury. This myocardial attack is a well-identified independent prognostic factor of postoperative morbidity and mortality. The quantification of these myocardial lesions by the postoperative plasma release of troponin has proven its diagnostic and prognostic value. Cardiac magnetic resonance imaging (MRI) can accurately measure and characterize the size of myocardial lesions. These lesions are associated with a poor prognosis. MRI can also characterize myocardial edema secondary to ischemia-reperfusion which has not yet been studied in the context of CPB. It is therefore necessary, in a mechanistic approach, to quantify the respective share of necrosis, edema and reperfusion lesions during cardiac surgery under CPB in order to better understand these phenomena and to propose effective strategies for the prevention of these myocardial lesions.the relationship between the postoperative release of troponin and the amount of myocardial necrosis and edema measured by cardiac MRI will be assessed.The hypothesis is to demonstrate a positive correlation between imaging and biology in order to better understand the perioperative myocardial lesion processes. This is an interventional study prospective, exploratory, in cardiac imaging, non-comparative and single-center, including 30 patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRI1 MRI 5 days after surgery (-1; +4 days), with intravenous administration of gadolinium
BIOLOGICALPostoperative dosage of released troponinDosage of troponin I Hs H4, H8, H12, H24, H48, and H72 after the aortic cross-unclamping.

Timeline

Start date
2020-12-02
Primary completion
2023-01-12
Completion
2023-01-12
First posted
2020-07-29
Last updated
2025-09-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04490785. Inclusion in this directory is not an endorsement.